Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Espitia

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
La Revue De Medecine Interne|November 22, 2017
[Validity and reproducibility of two direct observation assessment forms for evaluation of internal medicine residents' clinical skills]P Pottier, F Cohen Aubart, O Steichen, et al.
Rehabilitacion|June 22, 2026
[Respiratory Muscle Training Using the Innovative TriBURTER Device in Patients Undergoing Cardiovascular Surgery: A Pilot Study]N Peña Novoa, E Rincón Castillo, S Sanabria Barrera, et al.
La Revue De Medecine Interne|October 20, 2009
[Acute dyspnea in a 48-year-old man]C Agard, O Grossi, S Pattier, et al.
Annales De Dermatologie Et De Venereologie|December 13, 2017
[Late-onset systemic sclerosis: A retrospective study of 27 patients diagnosed after the age of 70]A Achille, L Journeau, O Espitia, et al.
Journal of Medicinal Chemistry|November 14, 1997
5-(N-oxyaza)-7-substituted-1,4-dihydroquinoxaline-2,3-diones: novel, systemically active and broad spectrum antagonists for NMDA/glycine, AMPA, and kainate receptorsS X Cai, J C Huang, S A Espitia, et al.
Biochemical Pharmacology|May 13, 2022
Resolvin E1 attenuates doxorubicin-induced endothelial senescence by modulating NLRP3 inflammasome activationLicia Shamoon, Jenaro A Espitia-Corredor, Pilar Dongil, et al.
Journal of Medicinal Chemistry|February 28, 1997
Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptorS X Cai, S M Kher, Z L Zhou, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|August 20, 2022
Resolvin E1 attenuates doxorubicin-induced cardiac fibroblast senescence: A key role for IL-1βJenaro A Espitia-Corredor, Licia Shamoon, Francisco Olivares-Silva, et al.
Bioorganic & Medicinal Chemistry|August 16, 2001
Synthesis and SAR of 5-, 6-, 7- and 8-aza analogues of 3-aryl-4-hydroxyquinolin-2(1H)-one as NMDA/glycine site antagonistsZ L Zhou, J M Navratil, S X Cai, et al.
Journal of Medicinal Chemistry|November 8, 1996
Analogs of 3-hydroxy-1H-1-benzazepine-2,5-dione: structure-activity relationship at N-methyl-D-aspartate receptor glycine sitesA P Guzikowski, S X Cai, S A Espitia, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
La Revue De Medecine Interne|November 22, 2017
[Validity and reproducibility of two direct observation assessment forms for evaluation of internal medicine residents' clinical skills]P Pottier, F Cohen Aubart, O Steichen, et al.
Rehabilitacion|June 22, 2026
[Respiratory Muscle Training Using the Innovative TriBURTER Device in Patients Undergoing Cardiovascular Surgery: A Pilot Study]N Peña Novoa, E Rincón Castillo, S Sanabria Barrera, et al.
La Revue De Medecine Interne|October 20, 2009
[Acute dyspnea in a 48-year-old man]C Agard, O Grossi, S Pattier, et al.
Annales De Dermatologie Et De Venereologie|December 13, 2017
[Late-onset systemic sclerosis: A retrospective study of 27 patients diagnosed after the age of 70]A Achille, L Journeau, O Espitia, et al.
Journal of Medicinal Chemistry|November 14, 1997
5-(N-oxyaza)-7-substituted-1,4-dihydroquinoxaline-2,3-diones: novel, systemically active and broad spectrum antagonists for NMDA/glycine, AMPA, and kainate receptorsS X Cai, J C Huang, S A Espitia, et al.
Biochemical Pharmacology|May 13, 2022
Resolvin E1 attenuates doxorubicin-induced endothelial senescence by modulating NLRP3 inflammasome activationLicia Shamoon, Jenaro A Espitia-Corredor, Pilar Dongil, et al.
Journal of Medicinal Chemistry|February 28, 1997
Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptorS X Cai, S M Kher, Z L Zhou, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|August 20, 2022
Resolvin E1 attenuates doxorubicin-induced cardiac fibroblast senescence: A key role for IL-1βJenaro A Espitia-Corredor, Licia Shamoon, Francisco Olivares-Silva, et al.
Bioorganic & Medicinal Chemistry|August 16, 2001
Synthesis and SAR of 5-, 6-, 7- and 8-aza analogues of 3-aryl-4-hydroxyquinolin-2(1H)-one as NMDA/glycine site antagonistsZ L Zhou, J M Navratil, S X Cai, et al.
Journal of Medicinal Chemistry|November 8, 1996
Analogs of 3-hydroxy-1H-1-benzazepine-2,5-dione: structure-activity relationship at N-methyl-D-aspartate receptor glycine sitesA P Guzikowski, S X Cai, S A Espitia, et al.
Pageof 3